Agilent Technologies Inc. | Large-cap | Healthcare
$120.66
0.17%
| Agilent Technologies Stock Comparison:
Agilent Technologies vs Thermo FisherAgilent Technologies vs DanaherAgilent Technologies vs Idexx LaboratoriesAgilent Technologies vs Iqvia HoldingsAgilent Technologies vs Mettler-ToledoAgilent Technologies vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 6.5B
Gross Profit 3.5B 54.30%
Operating Income 1.5B 22.86%
Net Income 1.3B 19.80%
EPS (Diluted) $4.43

Balance Sheet Metrics

Total Assets 11.8B
Total Liabilities 5.9B
Shareholders Equity 5.9B
Debt to Equity 1.01

Cash Flow Metrics

Operating Cash Flow 1.7B
Free Cash Flow 1.4B

Revenue & Profitability Trend

Agilent Technologies Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 6.5B 6.8B 6.8B 6.3B 5.3B
Cost of Goods Sold 3.0B 3.4B 3.1B 2.9B 2.5B
Gross Profit 3.5B 3.5B 3.7B 3.4B 2.8B
Operating Expenses 2.0B 2.1B 2.1B 2.1B 2.0B
Operating Income 1.5B 1.4B 1.6B 1.3B 846.0M
Pre-tax Income 1.5B 1.3B 1.5B 1.4B 842.0M
Income Tax 232.0M 99.0M 250.0M 150.0M 123.0M
Net Income 1.3B 1.2B 1.3B 1.2B 719.0M
EPS (Diluted) $4.43 $4.19 $4.18 $3.94 $2.30

Income Statement Trend

Agilent Technologies Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 4.0B 4.2B 3.8B 3.8B 3.4B
Non-Current Assets 7.9B 6.6B 6.8B 6.9B 6.2B
Total Assets 11.8B 10.8B 10.5B 10.7B 9.6B
Liabilities
Current Liabilities 1.9B 1.6B 1.9B 1.7B 1.5B
Non-Current Liabilities 4.1B 3.3B 3.4B 3.6B 3.3B
Total Liabilities 5.9B 4.9B 5.2B 5.3B 4.8B
Equity
Total Shareholders Equity 5.9B 5.8B 5.3B 5.4B 4.9B

Balance Sheet Composition

Agilent Technologies Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 1.3B 1.2B 1.3B 1.2B 719.0M
Operating Cash Flow 1.7B 1.5B 1.2B 1.6B 849.0M
Investing Activities
Capital Expenditures -378.0M -298.0M -291.0M -187.0M -118.0M
Investing Cash Flow -1.3B -310.0M -338.0M -749.0M -147.0M
Financing Activities
Dividends Paid -274.0M -265.0M -250.0M -236.0M -222.0M
Financing Cash Flow -829.0M -997.0M -1.4B -751.0M -1.1B
Free Cash Flow 1.4B 1.5B 1.0B 1.3B 802.0M

Cash Flow Trend

Agilent Technologies Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 28.60
Forward P/E 20.55
Price to Book 5.37
Price to Sales 4.98
PEG Ratio 20.55

Profitability Ratios

Profit Margin 17.59%
Operating Margin 23.56%
Return on Equity 18.88%
Return on Assets 8.46%

Financial Health

Current Ratio 2.09
Debt to Equity 60.04
Beta 1.23

Per Share Data

EPS (TTM) $4.06
Book Value per Share $21.61
Revenue per Share $23.18

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
a 33.0B 28.60 5.37 18.88% 17.59% 60.04
Thermo Fisher 152.5B 23.69 3.09 13.70% 15.19% 69.23
Danaher 140.5B 37.98 2.76 7.22% 15.81% 34.56
Idexx Laboratories 42.1B 48.33 29.21 59.33% 22.76% 73.16
Iqvia Holdings 27.4B 21.64 4.61 21.64% 8.61% 242.91
Mettler-Toledo 24.0B 28.82 -135.91 -680.23% 22.17% -11.40

Financial data is updated regularly. All figures are in the company's reporting currency.